We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
According to sources close to the talks, a deal on an intellectual property waiver for COVID-19 vaccines at the World Trade Organization (WTO) was no closer to acceptance on Monday despite backing from the US, due to expected scepticism about a new draft
People familiar with the matter say that since the US decided recently to back a proposed patent waiver on COVID-19 vaccines, pharmaceutical trade groups have been moving to support Germany, that have expressed opposition to the idea